Rankings
▼
Calendar
JANX Q4 2023 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$852M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-13.5% YoY
Gross Profit
$2M
78.4% margin
Operating Income
-$16M
-655.7% margin
Net Income
-$12M
-477.8% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
-2.2%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$380M
Total Liabilities
$36M
Stockholders' Equity
$344M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$3M
-13.5%
Gross Profit
$2M
$3M
-32.2%
Operating Income
-$16M
-$18M
+11.7%
Net Income
-$12M
-$16M
+26.8%
← FY 2023
All Quarters
Q1 2024 →